Pharma Funds: Investment Potential
Dalal Street Investment Journal|December 18, 2023
Investors often assume that investing in the pharmaceutical sector is a safe bet given that its products and services are always in demand. However, investing in pharmaceutical funds requires a constant study of the market and the sector. Moreover, as they are more focused ona single sector, they offer no diversification benefit. Hence, even though they offer potentially higher risk, their underlying return is also on the higher end. Therefore, before you head towards investing in them, understand your risk profile, investment objectives and time horizon
Pharma Funds: Investment Potential

The Indian equity market, over the past few quarters, has witnessed substantial gains. This has resulted in heightened inflows into equity mutual funds. One important trend is sectoral or thematic mutual funds that are capturing investors’ attention, drawing in nearly ₹14,000 crore of inflows in the last five months. On a year-to-date (YTD) basis, sectoral or thematic funds had a cumulative net inflow of ₹22,871 crore.

This surge signifies a growing interest among investors willing to take on higher risks for potential rewards. Recent data from the Association of Mutual Funds in India (AMFI) highlights a shift in these funds’ fortunes, as indicated in the table below:

After a withdrawal of ₹169 crore in May, sectoral or thematic funds have consistently seen inflows since June 2023. In the month of October, thematic funds got a huge inflow of ₹3,896 crore, the second highest among equity categories. These sectoral or thematic funds focus on specific sectors or themes and are for investors comfortable with higher risk. In this article, we would be speaking about one of the standout performers of 2020 that experienced a downturn from August 2021 to March 2023. Nonetheless, it started to rebound at the onset of the financial year 2024. Indeed, we are talking about pharmaceutical funds.

The Nifty Pharma index surged from a low of 11,542.45 to a high of 16,279.10, resulting in impressive absolute returns of 41 per cent over a mere nine-month period. Concurrently, pharmaceutical funds delivered an average return of 38 per cent during this timeframe. Such a significant growth might instigate a fear of missing out (FOMO) among numerous investors.

This story is from the December 18, 2023 edition of Dalal Street Investment Journal.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the December 18, 2023 edition of Dalal Street Investment Journal.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM DALAL STREET INVESTMENT JOURNALView All
Are Small-Cap Funds Still Lucrative?
Dalal Street Investment Journal

Are Small-Cap Funds Still Lucrative?

While the high growth potential of small-cap funds is enticing, the investment comes with a significant downside. Compared to large-cap funds, small-caps experience deeper maximum drawdown during market downturns. The article examines the how, why and when of investing in small-cap funds

time-read
8 mins  |
June 03, 2024
Small-Caps: Book Profits Or Remain Invested?
Dalal Street Investment Journal

Small-Caps: Book Profits Or Remain Invested?

Our analysis of the performance of small-cap stocks indicates that while the broader markets are expected to rise, caution is advised regarding extreme valuations. Therefore, it is recommended to choose quality small-cap stocks based on thorough fundamental and technical research. The article highlights the reasons for doing so

time-read
5 mins  |
June 03, 2024
Can The Global Equities Sustain The Bull Run In The Second Half Of 2024?
Dalal Street Investment Journal

Can The Global Equities Sustain The Bull Run In The Second Half Of 2024?

After four weeks of gains, the markets paused in the past fortnight, despite outstanding earnings from the Al leader NVIDIA. For the year, the S&P 500 remains up by about 10 per cent, and we view some consolidation after the recent strong performance.

time-read
2 mins  |
June 03, 2024
Shifting Sands: Will FIIs Return To Indian Shores?
Dalal Street Investment Journal

Shifting Sands: Will FIIs Return To Indian Shores?

The Indian equity market currently grapples with a cloud of uncertainty, with volatility reaching its peak. Fils have been consistent net sellers for months, offloading a significant ₹1.20 lakh crore in 2024 alone. This raises a critical question: Is this indicative of a fundamental shift in their view on the Indian growth story, or are they contending with temporary headwinds? Mandar Wagh delves into the potential reasons behind Fil selling and explores when Fils might return to India

time-read
8 mins  |
June 03, 2024
ON A SLIPPERY SLOPE
Dalal Street Investment Journal

ON A SLIPPERY SLOPE

The recent ban on acquiring new customers online and the issue of credit cards has put a spanner in the operations of the bank. Given that the timeline for its operational turnaround is uncertain, the stock has lost its appeal

time-read
5 mins  |
June 03, 2024
Resilience Rules The Roost
Dalal Street Investment Journal

Resilience Rules The Roost

The key domestic indices reached all-time highs even though Nifty VIX, known as the 'fear gauge', has doubled in value over the past one month

time-read
2 mins  |
June 03, 2024
Risk Profiling in Mutual Funds
Dalal Street Investment Journal

Risk Profiling in Mutual Funds

Whether you lean towards equity, debt or hybrid investments, recognising your risk tolerance is paramount. By conducting a risk profile assessment, you gain foresight into potential investment risks, mitigating any future unease before it arises. Rakesh Deshmukh takes a closer look at the scenario to see how it works

time-read
8 mins  |
May 20, 2024
"The Future Of Mutual Funds Looks Promising"
Dalal Street Investment Journal

"The Future Of Mutual Funds Looks Promising"

Given that the current landscape of mutual funds is dynamic and evolving, Rashida Kalolwala, Coo, Edelweiss Mutual Fund, states in this interview that the shift towards digitalisation and the emphasis on transparency are some of the factors that will further propel the growth of the mutual fund industry

time-read
4 mins  |
May 20, 2024
ETF Vs Stock Liquidity
Dalal Street Investment Journal

ETF Vs Stock Liquidity

Exchange traded funds (ETFs) have undeniably revolutionised the investment landscape for both investors and financial services professionals alike. They offer opportunities to diversify portfolios, manage risk more effectively, and reduce investment costs. However, to fully harness these benefits, it's crucial to dispel confusion and misconceptions surrounding ETFs Liquidity. The article examines the working of ETFs, their liquidity and how investors can capitalise on them

time-read
7 mins  |
May 20, 2024
Road To Prosperity Through Mutual Funds
Dalal Street Investment Journal

Road To Prosperity Through Mutual Funds

In the pursuit of financial freedom and wealth creation, mutual funds have emerged as a beacon of opportunity for investors in India.

time-read
2 mins  |
May 20, 2024